Author Title [ Type(Desc)] Year
Filters: Author is Srivastava, Alok  [Clear All Filters]
Journal Article
Chendamarai E, Ganesan S, Alex AAbu, Kamath V, Nair SC, Nellickal AJose, Janet NBeryl, Srivastava V, Lakshmi KM, Viswabandya A, et al. Comparison of Newly Diagnosed and Relapsed Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide: Insight into Mechanisms of Resistance. PLoS One. 2015;10(3):e0121912.
Mathews V, George B, Viswabandya A, Abraham A, Ahmed R, Ganapule A, Sindhuvi E, Lakshmi KM, Srivastava A. Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts. PLoS One. 2013;8(4):e61637.
Maddali M, Kulkarni UPrakash, Ravindra N, Arunachalam AKumar, Venkatraman A, Lionel S, Manipadam MTherese, Devasia AJ, Korula A, Fouzia NA, et al. Mutation profile in BCR-ABL1-negative myeloproliferative neoplasms: A single-center experience from India. Hematol Oncol Stem Cell Ther. 2021.
Viswanathan S, Rao M, Keating A, Srivastava A. Overcoming Challenges to Initiating Cell Therapy Clinical Trials in Rapidly Developing Countries: India as a Model. Stem Cells Transl Med. 2013.
Algwaiz G, Aljurf M, Koh M, Horowitz MM, Ljungman P, Weisdorf D, Saber W, Kodera Y, Szer J, Jawdat D, et al. Real-world issues and potential solutions in HCT during the COVID-19 pandemic: Perspectives from the WBMT and the CIBMTR's Health Services and International Studies Committee. Biol Blood Marrow Transplant. 2020.
Manian KV, Aalam SMohammed M, Bharathan SP, Srivastava A, Velayudhan SR. Understanding the Molecular Basis of Heterogeneity in Induced Pluripotent Stem Cells. Cell Reprogram. 2015.
Kulkarni U, Devasia AJ, Korula A, Na F, Pn N, Samoon YJ, Lakshmi KM, Abraham A, Srivastava A, Mathews V, et al. Use of non-cryopreserved peripheral blood stem cells (PBSC) is associated with adequate engraftment in patients with multiple myeloma undergoing an autologous transplant. Biol Blood Marrow Transplant. 2018.
Pasquini MC, Srivastava A, Ahmed SOsman, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale G, et al. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond. Hematol Oncol Stem Cell Ther. 2019.